Epidemiology & Public Health Poster III: Inflammatory Rheumatic Disease
Sunday, November 8, 2020
9:00 AM – 11:00 AM ET
Poster session.
Presentations:
9:00 AM – 11:00 AM ET
Passive Smoking Throughout the Life Course and the Risk of Incident Rheumatoid Arthritis in Adulthood Among Women Kazuki Yoshida, ScD – Brigham and Women's Hospital
9:00 AM – 11:00 AM ET
Risk of Malignant Melanoma and Nonmelanoma Skin Cancer in Rheumatoid Arthritis Patients Initiating Methotrexate versus Hydroxychloroquine Hemin Lee, MD – Brigham and Women's Hospital
9:00 AM – 11:00 AM ET
Prostate Cancer Risk Is Not Increased in Rheumatoid Arthritis After Accounting for Retention in a Health Care System Kaitlyn Brittan, MD – University of Nebraska Medical Center
9:00 AM – 11:00 AM ET
Long-term Weight Changes and Risk of Rheumatoid Arthritis Among Women in a Prospective Cohort: A Marginal Structural Model Approach Nathalie Marchand, ScD – Brigham and Women's Hospital
9:00 AM – 11:00 AM ET
The Incidence, Mortality, and Economic Burden of Potentially Preventable Infections in Rheumatoid Arthritis Patients Soumyasri Kambhatla, MD – Rush University
9:00 AM – 11:00 AM ET
Risk of Non-vertebral Fractures Among Rheumatoid Arthritis Patients Treated with Biologic or Targeted-Synthetic DMARDs: A Multi-Database Comparative Safety Study Seoyoung C. Kim, MD, ScD – Brigham and Women's Hospital
9:00 AM – 11:00 AM ET
Post-menopausal Rheumatoid Arthritis Is Inversely Associated with Lifetime High Level of Estrogen Exposure in the French E3N Cohort CARINE SALLIOT, MD, MSc – CHR orleans
9:00 AM – 11:00 AM ET
Atopic Dermatitis and Risk of Incident Rheumatoid Arthritis: A Systematic Review and Meta-analysis Patompong Ungprasert, MD, MS – Cleveland Clinic, Cleveland, OH
9:00 AM – 11:00 AM ET
Assessing Improved Risk Prediction of Seropositive Rheumatoid Arthritis by Environmental, Genetic, and Preclinical Plasma Metabolite Factors Lilia Bouzit, MS – Harvard Chan School of Public Health
9:00 AM – 11:00 AM ET
Missing Data and Multiple Imputation in Rheumatoid Arthritis Registries Using Sequential Random Forest Method Adeeba Al-Herz, MD, FRCPC, FRCP – Al-Amiri Hospital
9:00 AM – 11:00 AM ET
Infection and Malignancy Outcomes in Patients with RA Treated with Abatacept: Results from a Multinational Surveillance Study Merete Lund Hetland, MD, PhD – Rigshospitalet
9:00 AM – 11:00 AM ET
Effectiveness, Safety and Quality of Life with Tofacitinib Treatment in Adult Patients with Rheumatoid Arthritis Under Routine Clinical Care: First Interim Results from a German Non-Interventional, Prospective, Multi-Center Study Frank Behrens, MD – Rheumatology & Fraunhofer TMP Goethe University Frankfurt, Germany
9:00 AM – 11:00 AM ET
The Global Prevalence of Rheumatoid Arthritis: A Meta-Analysis Khalid B. Almutairi, BS, MSc – The University of Western Australia
9:00 AM – 11:00 AM ET
National Burden of RA in Canada 1990-2017: Findings from the Global Burden of Disease Study 2017 Nejat Hassen, MSc – University of British Columbia, Arthritis Research Canada
9:00 AM – 11:00 AM ET
Disease Modifying Anti-rheumatic Drugs, Biologics and Corticosteroid Use in Older Patients with Rheumatoid Arthritis over 20 Years John G. Hanly, MD – Dalhousie University, Halifax, NS, Canada
9:00 AM – 11:00 AM ET
The Prevalence and Risk Factors for Liver Fibrosis Among Rheumatoid Arthritis (RA) Patients on Disease-Modifying Anti-rheumatic Drugs (DMARDs) Chou Luan Tan, MBBS, MRCP – Hospital Sultanah Bahiyah, Kementerian Kesihatan Malaysia
9:00 AM – 11:00 AM ET
Annual Cardiac or Orthopedic Procedure Volume in Gout versus Rheumatoid Arthritis: A National Time-trends Study Jasvinder Singh, MD, MPH – University of Alabama at Birmingham
9:00 AM – 11:00 AM ET
Racial and Ethnic Disparities in the Risk of Preterm Birth Among Women with Systemic Lupus Erythematosus or Rheumatoid Arthritis with Varying Reference Groups Lena Sabih, MD – Saint Louis University
9:00 AM – 11:00 AM ET
Seasonal Variation in the Treat-to-Target Rate of Rheumatoid Arthritis (RA) and Systemic Lupus Erythematosus (SLE): A Cohort Study on Self-reported Data from Smart System of Disease Management (SSDM) Lijun Wu, MD – People's Hospital of Xinjiang Uygur Autonomous Region
9:00 AM – 11:00 AM ET
Outdoor Air Pollution and Systemic Lupus Erythematosus George Stojan, MD – Johns Hopkins University
9:00 AM – 11:00 AM ET
Relationship Between Skin-related Quality of Life, Psychosocial Stress, and Race in Cutaneous Lupus Erythematosus Cristina Drenkard, MD, PhD – Emory University
9:00 AM – 11:00 AM ET
Organ Damage in Systemic Lupus Erythematosus Is Attributable More to Comorbidity (Hypertension) and Less to Socioeconomic Status Romy Kallas, MD – Lankenau Medical Center
9:00 AM – 11:00 AM ET
Declining In-hospital Mortality Gap in Lupus Compared to Non-lupus Hospitalizations: A National Study Jasvinder Singh, MD, MPH – University of Alabama at Birmingham
9:00 AM – 11:00 AM ET
Epidemiology and Sociodemographic Distribution of Upper Gastrointestinal Bleeding Among Medicaid Beneficiaries with Systemic Lupus Erythematosus Chang XU, MS – Brigham and Women's Hospital
9:00 AM – 11:00 AM ET
Time Trends in the Incidence of Systemic Lupus Erythematosus: A 40-Year Study Ali Duarte-Garcia, MD – Mayo Clinic
9:00 AM – 11:00 AM ET
Prevalence Estimates for Systemic Lupus Erythematosus over Four Decades Ali Duarte-Garcia, MD – Mayo Clinic
9:00 AM – 11:00 AM ET
The Incidence, Mortality, and Economic Burden of Potentially Preventable Infections in Systemic Lupus Erythematosus Patients Estefania Gauto-Mariotti, MD – John H. Stroger Jr. Hospital of Cook County
9:00 AM – 11:00 AM ET
The National Prevalence of Clinically Diagnosed Psoriatic Arthritis in Sweden 2017 Sofia Exarchou, MD, PhD – Lund University
9:00 AM – 11:00 AM ET
Probabilistic Linkage of a Cohort of Individuals with Symptoms Suggestive of Early Spondyloarthritis and the French National Healthcare Database Clementina Lopez-Medina, PhD – Cochin Hospital, Rheumatology Department
9:00 AM – 11:00 AM ET
Clinical Characteristics of Patients with Axial Spondyloarthritis in China: Results from the ChinaAS Registry Runsheng Wang, MD, MHS – Columbia University Irving Medical Center
9:00 AM – 11:00 AM ET
Pain Medication Use Among Ankylosing Spondylitis and Psoriatic Arthritis Patients Before and After Initiation of Biologic Therapy Hiangkiat Tan, MS – Healthcore, Inc
9:00 AM – 11:00 AM ET
Real World Treatment Patterns Among Patients with Psoriatic Arthritis Treated with Ixekizumab Alexis Ogdie, MD, MSCE – University of Pennsylvania
9:00 AM – 11:00 AM ET
Epidemiology and Geographic Evaluation of ANCA-associated Vasculitis (AAV) at a Rural Academic Health Center Utilizing an Electronic Health Record (EHR) Eva I. Rottmann, DO – Geisinger Health System
